BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 14310877)

  • 1. [COMPARATIVE STUDY OF THE SPECTRUM OF ACTION OF ANTINEOPLASTIC PREPARATIONS OF THE ALKYLATING AGENT GROUP ON TRANSPLANTABLE TUMORS IN MICE].
    BOKAEVA SS
    Biull Eksp Biol Med; 1965 Mar; 59():86-8. PubMed ID: 14310877
    [No Abstract]   [Full Text] [Related]  

  • 2. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. II. THERAPEUTIC ACTIVITIES OF ALKYLATING AGENTS AND REFERENCE COMPOUNDS AGAINST VARIOUS TUMOR SYSTEMS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:403+. PubMed ID: 14278902
    [No Abstract]   [Full Text] [Related]  

  • 3. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. I.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1-401. PubMed ID: 14278901
    [No Abstract]   [Full Text] [Related]  

  • 4. [CHANGES IN THE AMOUNT OF SULFHYDRYL COMPOUNDS IN THE BLOOD SERUM AND TISSUES OF TRANSPLANTED RAT TUMORS UNDER THE INFLUENCE OF ANTINEOPLASTIC ALKYLATING PREPARATIONS].
    KULIK GI
    Vopr Onkol; 1964; 10():70-4. PubMed ID: 14259823
    [No Abstract]   [Full Text] [Related]  

  • 5. A STUDY OF COMPARATIVE CHEMICAL AND BIOLOGICAL ACTIVITIES OF ALKYLATING AGENTS.
    BARDOS TJ; DATTA-GUPTA N; HEBBORN P; TRIGGLE DJ
    J Med Chem; 1965 Mar; 8():167-74. PubMed ID: 14335145
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE EFFECT OF ALKYLATING CYTOSTATICS ON THE NUCLEIC ACID METABOLISM OF EHRLICH ASCITES TUMOR CELLS].
    LISS E; PALME G
    Z Krebsforsch; 1964 Jul; 66():196-206. PubMed ID: 14256642
    [No Abstract]   [Full Text] [Related]  

  • 7. [THE INFLUENCE OF PRELIMINARY TREATMENT OF RATS WITH ALKYLATING SUBSTANCES AND OTHER TOXINS ON THE GROWTH OF YOSHIDA SARCOMA].
    SCHMAEHL D; SATTLER W
    Arzneimittelforschung; 1964 Jul; 14():746-50. PubMed ID: 14344711
    [No Abstract]   [Full Text] [Related]  

  • 8. FURTHER INVESTIGATIONS OF HETEROCYCLIC ALKYLATING AGENTS.
    PRESTON RK; PECK RM; BREUNINGER ER; MILLER AJ; CREECH HJ
    J Med Chem; 1964 Jul; 7():471-80. PubMed ID: 14221129
    [No Abstract]   [Full Text] [Related]  

  • 9. EXPERIMENTAL CHEMOTHERAPY STUDIES. IV. THE PROTECTIVE ACTION OF MERCAPTOALKYLAMINES AGAINST ALKYLATING AGENTS.
    RUTMAN RJ; LEWIS FS; PRICE CC
    Cancer Res; 1964 May; 24():626-33. PubMed ID: 14188465
    [No Abstract]   [Full Text] [Related]  

  • 10. CHEMOTHERAPY OF BRAIN TUMORS. I. TRANSPLANTED MURINE EPENDYMOBLASTOMAS.
    SOLOWAY AH; MARK VH; DUKAT EG; KJELLBERG RN
    Cancer Chemother Rep; 1964 Mar; 36():1-4. PubMed ID: 14152269
    [No Abstract]   [Full Text] [Related]  

  • 11. Halomethyl-1,2,3-triazole derivatives: a new type of alkylating agent active in mouse transplantable tumors.
    Contreras A; Sánchez-Pérez RM; Alonso G
    Cancer Chemother Pharmacol; 1978; 1(4):243-7. PubMed ID: 750111
    [No Abstract]   [Full Text] [Related]  

  • 12. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 13. [COMPARATIVE STUDIES ON CYTOSTATIC ALKYLATING REACTIONS].
    WEITZEL G; SCHNEIDER F; FRETZDORFF AM; SEYNSCHE K; FINGER H
    Krebsforsch Krebsbekampf; 1964; 30():156-63. PubMed ID: 14283701
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-(BETA-CHLOROETHYL)-3-CARBAMYLPYRIDINIUM CHLORIDE. PROTOTYPE OF A NEW CLASS OF LATENTLY CYTOTOXIC POTENTIAL ANTITUMOR AGENTS.
    FRIEDMAN OM; POLLAK K; KHEDOURI E
    J Med Chem; 1963 Jul; 6():462-3. PubMed ID: 14184911
    [No Abstract]   [Full Text] [Related]  

  • 15. PLASMA CELL NEOPLASM ARISING IN A CAF MOUSE. CHARACTERISTICS AND RESPONSE TO CERTAIN CHEMOTHERAPEUTIC AGENTS.
    YANCEY ST
    J Natl Cancer Inst; 1964 Sep; 33():373-82. PubMed ID: 14207853
    [No Abstract]   [Full Text] [Related]  

  • 16. HISTOLOGICAL AND HISTOCHEMICAL DATA ON THE PROCESS OF REGRESSION OF EXPERIMENTAL TUMOURS INDUCED BY ALKYLATING AGENTS.
    PRESNOV MA
    Acta Unio Int Contra Cancrum; 1964; 20():126-30. PubMed ID: 14151866
    [No Abstract]   [Full Text] [Related]  

  • 17. SOME MORPHOLOGICAL EFFECTS OF ALKYLATING AGENTS.
    BIESELE JJ
    Exp Cell Res; 1963; 24():SUPPL9:525-34. PubMed ID: 14046252
    [No Abstract]   [Full Text] [Related]  

  • 18. On the mechanism of action of the alkylating agents. I. Interaction of alkylating agents with nucleic acids.
    TRAMS EG; NADKARNI MV; SMITH PK
    Cancer Res; 1961 May; 21():560-6. PubMed ID: 13777867
    [No Abstract]   [Full Text] [Related]  

  • 19. COMPARATIVE PHARMACOLOGY OF ALKYLATING AGENTS. 3. TOXICITY DATA ON MONKEYS AND DOGS.
    SCHMIDT LH; FRADKIN R; SULLIVAN R; FLOWERS A
    Cancer Chemother Rep; 1965 Jan; 18():SUPPL 2:1017+. PubMed ID: 14278900
    [No Abstract]   [Full Text] [Related]  

  • 20. [Selectivity of the antitumor action of 2 alkylating compounds with different carrier structures].
    Astardzhieva Z; Stoichkov I
    Eksp Med Morfol; 1988; 27(2):14-7. PubMed ID: 3168903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.